Bassett Hargrove Investment Counsel’s AbbVie ABBV Stock Holding History

Bassett Hargrove Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$343K	Hold	2,300	–	–	0.58%	41
2023 Q2	$374K	Hold	2,300	–	–	0.7%	43
2023 Q1	$367K	Hold	2,300	–	–	0.64%	41
2022 Q4	$374K	Hold	2,300	–	–	0.7%	43
2022 Q3	$309K	Buy	+2,300	New	+$330K	0.63%	44
2022 Q1	$373K	Hold	2,300	–	–	0.57%	43
2021 Q4	$311K	Hold	2,300	–	–	0.45%	44
2021 Q3	$259K	Hold	2,300	–	–	0.39%	47
2021 Q2	$259K	Buy	+2,300	New	+$259K	0.39%	47

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bassett Hargrove Investment Counsel's ABBV Position: Q3 2023 in Review

Bassett Hargrove Investment Counsel held its AbbVie (ABBV) position steady in Q3 2023 at 2,300 shares worth $343K. The position accounts for 0.58% of the portfolio, ranked #41.

Bassett Hargrove Investment Counsel first reported a position in ABBV in Q2 2021 and has held it in 9 quarters since. The position peaked at $374K in Q2 2023. 3,111 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

Bassett Hargrove Investment Counsel held 2,300 shares of AbbVie worth $343K as of Q3 2023.
Bassett Hargrove Investment Counsel left its AbbVie share count unchanged in Q3 2023.
AbbVie made up 0.58% of Bassett Hargrove Investment Counsel's portfolio in Q3 2023, its #41 holding.
Bassett Hargrove Investment Counsel first reported a position in AbbVie in Q2 2021 and has held it in 9 quarters since.
Bassett Hargrove Investment Counsel's AbbVie position peaked at $374K in Q2 2023.
3,111 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Bassett Hargrove Investment Counsel's 13F filing for Q3 2023, filed 26 Oct 2023.